Key result
Chemotherapy following surgical biopsy for cardiac angiosarcoma resulted in a survival of 28 months in a man presenting with hemorrhagic tamponade.
Case Report (n=1)
Early detection using advanced imaging modalities and treatment with chemotherapy can extend survival in patients with cardiac angiosarcoma.
Supports hypothesis of chemotherapy benefit in cardiac angiosarcoma; leaves open confirmation via prospective trials.
Prognosis of angiosarcoma, the most common primary malignant cardiac tumor, is very poor. An early detection and treatment may extend survival beyond one year. Newer imaging modalities, including magnetic resonance imaging (MRI), play an important role in the evaluation of cardiac masses. The case of a man admitted to the emergency room for a cardiac tamponade is reported. Thoracic computed tomography and MRI diagnosed a pericardial tumor, for which surgical biopsy revealed an angiosarcoma. Chemotherapy was started, and the patient survived for 28 months. Etiologies of hemorrhagic tamponades are discussed, as well as treatment of cardiac angiosarcoma.
No takes yet. Share an insight, caveat, or question.
Vautrin et al. (2010) conducted a case report in Hemorrhagic tamponade due to cardiac angiosarcoma (n=1). Chemotherapy was evaluated on Survival. Chemotherapy following surgical biopsy for cardiac angiosarcoma resulted in a survival of 28 months in a man presenting with hemorrhagic tamponade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: